Metropolitan Life Insurance Company (MetLife)’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,659
| Closed | -$88.3K | – | 2527 |
|
|
2022
Q4 | $88.3K | Buy |
2,659
+139
| +6% | +$4.48K | ﹤0.01% | 1123 |
|
|
2022
Q3 | $79.5K | Hold |
2,520
| – | – | ﹤0.01% | 1158 |
|
|
2022
Q2 | $76.7K | Hold |
2,520
| – | – | ﹤0.01% | 1222 |
|
|
2022
Q1 | $65.4K | Sell |
2,520
-9,042
| -78% | -$215K | ﹤0.01% | 1442 |
|
|
2021
Q4 | $236K | Sell |
11,562
-2,403
| -17% | -$46.1K | ﹤0.01% | 1915 |
|
|
2021
Q3 | $269K | Hold |
13,965
| – | – | ﹤0.01% | 1871 |
|
|
2021
Q2 | $310K | Buy |
13,965
+733
| +6% | +$15.5K | ﹤0.01% | 1840 |
|
|
2021
Q1 | $347K | Sell |
13,232
-716
| -5% | -$17K | 0.01% | 1653 |
|
|
2020
Q4 | $261K | Hold |
13,948
| – | – | ﹤0.01% | 1754 |
|
|
2020
Q3 | $237K | Hold |
13,948
| – | – | ﹤0.01% | 1676 |
|
|
2020
Q2 | $325K | Hold |
13,948
| – | – | 0.01% | 1505 |
|
|
2020
Q1 | $117K | Buy |
13,948
+246
| +2% | +$2.07K | ﹤0.01% | 1931 |
|
|
2019
Q4 | $134K | Sell |
13,702
-1,421
| -9% | -$13.3K | ﹤0.01% | 2161 |
|
|
2019
Q3 | $144K | Hold |
15,123
| – | – | ﹤0.01% | 2100 |
|
|
2019
Q2 | $180K | Hold |
15,123
| – | – | ﹤0.01% | 1955 |
|
|
2019
Q1 | $266K | Hold |
15,123
| – | – | ﹤0.01% | 1704 |
|
|
2018
Q4 | $263K | Buy |
15,123
+822
| +6% | +$14K | 0.01% | 1630 |
|
|
2018
Q3 | $213K | Hold |
14,301
| – | – | ﹤0.01% | 1968 |
|
|
2018
Q2 | $227K | Hold |
14,301
| – | – | ﹤0.01% | 1861 |
|
|
2018
Q1 | $203K | Hold |
14,301
| – | – | ﹤0.01% | 1886 |
|
|
2017
Q4 | $200K | Sell |
14,301
-17,444
| -55% | -$255K | ﹤0.01% | 1910 |
|
|
2017
Q3 | $454K | Hold |
31,745
| – | – | ﹤0.01% | 1756 |
|
|
2017
Q2 | $500K | Sell |
31,745
-1,075
| -3% | -$15.5K | ﹤0.01% | 1688 |
|
|
2017
Q1 | $453K | Hold |
32,820
| – | – | ﹤0.01% | 1715 |
|
|
2016
Q4 | $581K | Hold |
32,820
| – | – | ﹤0.01% | 1643 |
|
|
2016
Q3 | $633K | Hold |
32,820
| – | – | ﹤0.01% | 1552 |
|
|
2016
Q2 | $640K | Hold |
32,820
| – | – | ﹤0.01% | 1543 |
|
|
2016
Q1 | $676K | Hold |
32,820
| – | – | 0.01% | 1400 |
|
|
2015
Q4 | $673K | Hold |
32,820
| – | – | 0.01% | 1433 |
|
|
2015
Q3 | $561K | Hold |
32,820
| – | – | ﹤0.01% | 1566 |
|
|
2015
Q2 | $612K | Sell |
32,820
-2,185
| -6% | -$40.5K | ﹤0.01% | 1611 |
|
|
2015
Q1 | $668K | Hold |
35,005
| – | – | ﹤0.01% | 1408 |
|
|
2014
Q4 | $576K | Hold |
35,005
| – | – | ﹤0.01% | 1672 |
|
|
2014
Q3 | $619K | Hold |
35,005
| – | – | ﹤0.01% | 1585 |
|
|
2014
Q2 | $723K | Hold |
35,005
| – | – | 0.01% | 1568 |
|
|
2014
Q1 | $763K | Hold |
35,005
| – | – | 0.01% | 1531 |
|
|
2013
Q4 | $929K | Hold |
35,005
| – | – | 0.01% | 1376 |
|
|
2013
Q3 | $828K | Hold |
35,005
| – | – | 0.01% | 1399 |
|
|
2013
Q2 | $753K | Buy |
+35,005
| New | +$755K | 0.01% | 1420 |
|
Other funds holding VIVO
Metropolitan Life Insurance Company (MetLife)'s VIVO Position: Q1 2023 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 2,659 shares — an estimated $88.3K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in VIVO in Q2 2013 and held it in 39 quarters. The position peaked at $929K in Q4 2013. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 2,659 Meridian Bioscience Inc shares in Q1 2023, an estimated $88.3K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 39 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Meridian Bioscience Inc position peaked at $929K in Q4 2013.
- 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2023, filed 15 May 2023.